308 related articles for article (PubMed ID: 26161144)
1. The role of radiation therapy in the treatment of metastatic castrate-resistant prostate cancer.
Rose JN; Crook JM
Ther Adv Urol; 2015 Jun; 7(3):135-45. PubMed ID: 26161144
[TBL] [Abstract][Full Text] [Related]
2. Integrating bone targeting radiopharmaceuticals into the management of patients with castrate-resistant prostate cancer with symptomatic bone metastases.
Blacksburg SR; Witten MR; Haas JA
Curr Treat Options Oncol; 2015 Mar; 16(3):325. PubMed ID: 25777571
[TBL] [Abstract][Full Text] [Related]
3. Palliative radiotherapy for prostate cancer.
Boyer MJ; Salama JK; Lee WR
Oncology (Williston Park); 2014 Apr; 28(4):306-12. PubMed ID: 24839802
[TBL] [Abstract][Full Text] [Related]
4. Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group.
Brundage MD; Crook JM; Lukka H
Cancer Prev Control; 1998 Apr; 2(2):79-87. PubMed ID: 9765768
[TBL] [Abstract][Full Text] [Related]
5. Radiation for Treatment of Painful Bone Metastases.
Shiloh R; Krishnan M
Hematol Oncol Clin North Am; 2018 Jun; 32(3):459-468. PubMed ID: 29729781
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience with radium-223 in the treatment of patients with advanced castrate-resistant prostate cancer and symptomatic bone metastases.
Hague C; Logue JP
Ther Adv Urol; 2016 Jun; 8(3):175-80. PubMed ID: 27247627
[TBL] [Abstract][Full Text] [Related]
7.
Jessome R
J Med Imaging Radiat Sci; 2015 Jun; 46(2):156-161. PubMed ID: 31052089
[TBL] [Abstract][Full Text] [Related]
8. Isotope Therapy for Castrate-Resistant Prostate Cancer: Unique Sequencing and Combinations.
Sartor O
Cancer J; 2016; 22(5):342-346. PubMed ID: 27749328
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10. Radiation-based approaches for therapy and palliation of advanced prostate cancer.
Lewis B; Sartor O
Curr Opin Urol; 2012 May; 22(3):183-9. PubMed ID: 22453334
[TBL] [Abstract][Full Text] [Related]
11. New developments in metastatic prostate cancer therapy.
Manickavasagar T; Gilson C; Chowdhury S; Kirby R
Practitioner; 2015 Apr; 259(1781):21-4, 2-3. PubMed ID: 26529826
[TBL] [Abstract][Full Text] [Related]
12. (223)Ra and other bone-targeting radiopharmaceuticals-the translation of radiation biology into clinical practice.
Turner PG; O'Sullivan JM
Br J Radiol; 2015 Jun; 88(1050):20140752. PubMed ID: 25811095
[TBL] [Abstract][Full Text] [Related]
13. Current perspectives on bone metastases in castrate-resistant prostate cancer.
Logothetis C; Morris MJ; Den R; Coleman RE
Cancer Metastasis Rev; 2018 Mar; 37(1):189-196. PubMed ID: 29380085
[TBL] [Abstract][Full Text] [Related]
14. Radiation for bone metastases: conventional techniques and the role of systemic radiopharmaceuticals.
Janjan NA
Cancer; 1997 Oct; 80(8 Suppl):1628-45. PubMed ID: 9362430
[TBL] [Abstract][Full Text] [Related]
15. [Palliative Radiotherapy for Bone Metastases].
Nagakura H
Gan To Kagaku Ryoho; 2015 Nov; 42(11):1346-9. PubMed ID: 26602393
[TBL] [Abstract][Full Text] [Related]
16. Radium-223 dichloride in clinical practice: a review.
Florimonte L; Dellavedova L; Maffioli LS
Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1896-909. PubMed ID: 27121689
[TBL] [Abstract][Full Text] [Related]
17. Radiation for bone metastases.
Bourgeois DJ; Kraus S; Maaloof BN; Sartor O
Curr Opin Support Palliat Care; 2011 Sep; 5(3):227-32. PubMed ID: 21734581
[TBL] [Abstract][Full Text] [Related]
18. Radium-223 for the treatment of castration-resistant prostate cancer.
El-Amm J; Aragon-Ching JB
Onco Targets Ther; 2015; 8():1103-9. PubMed ID: 26056474
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapeutic approaches to metastatic disease.
Chow E; Wu J; Loblaw A; Perez CA
World J Urol; 2003 Sep; 21(4):229-42. PubMed ID: 12910364
[TBL] [Abstract][Full Text] [Related]
20. EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer.
Poeppel TD; Handkiewicz-Junak D; Andreeff M; Becherer A; Bockisch A; Fricke E; Geworski L; Heinzel A; Krause BJ; Krause T; Mitterhauser M; Sonnenschein W; Bodei L; Delgado-Bolton RC; Gabriel M
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):824-845. PubMed ID: 29234845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
